Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-029770
Filing Date
2025-06-05
Accepted
2025-06-05 18:13:13
Documents
3
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749161364.html 4  
1 FORM 4 wk-form4_1749161364.xml 4 3957
2 EX-24 primemedicine-powerofatt.htm EX-24 5159
3 primemedicine-powerofatt001.jpg GRAPHIC 307170
  Complete submission text file 0001628280-25-029770.txt   433713
Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Foster-Cheek Kaye I (Reporting) CIK: 0001312622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 251028468

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)